OBIO 8-K 2026-10-01

Orchestra BioMed Holdings, Inc. (OBIO) 8-K dated 2026-10-01 — accession 0001104659-26-112586. This URL is the filing, not the OBIO hub.

Orchestra BioMed Holdings, Inc. (OBIO) is a biotechnology company listed on NASDAQ.

Orchestra BioMed Holdings, Inc. filed a 8-K on 2026-10-01. Accession 0001104659-26-112586.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OBIO revenue for 2025-12-31 was $33.5M. Net income was -$52.7M. Revenue was up 1169.2% from 2024-12-31 to 2025-12-31. OBIO currently screens at market cap $231.7M.

Not investment advice. The OBIO SEC hub lists recent forms. The stock page is the research view.